COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment

Jagdish Khubchandani; Sushil K. Sharma; James H. Price; Michael Wiblishauser; Manoj Sharma; Fern J. Webb

doi:10.1007/s10900-020-00958-x

Keywords

VaccinationPopulationDemographyCoronavirus disease 2019 (COVID-19)BachelorMedicineGerontologyEnvironmental healthPolitical scienceImmunologyDisease

Affiliated Institutions

Related Publications

Vaccine hesitancy: the next challenge in the fight against COVID-19

Amiel A. Dror , Netanel Eisenbach , Shahar Taiber +5 more

Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, conc...

2020 European Journal of Epidemiology 1749 citations

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson , Gregory Barnsley , Jaspreet Toor +3 more

The first COVID-19 vaccine outside a clinical trial setting was administered on Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 Vaccines G...

2022 The Lancet Infectious Diseases 1707 citations

Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA

Sahil Loomba , Alexandre de Figueiredo , Simon J. Piatek +2 more

Widespread acceptance of a vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will be the next major step in fighting the coronavirus disease 2019 (COVID-1...

2021 Nature Human Behaviour 1709 citations

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas , Frederick J. Angulo , John M. McLaughlin +12 more

Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Healt...

2021 The Lancet 1722 citations

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan , Noam Barda , Eldad Kepten +7 more

This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with...

2021 New England Journal of Medicine 2739 citations

Publication Info

Year: 2021
Type: article
Volume: 46
Issue: 2
Pages: 270-277
Citations: 1095
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1095

OpenAlex

Cite This

APA Style

                            
                                
                                    Jagdish Khubchandani, 
                                
                                    Sushil K. Sharma, 
                                
                                    James H. Price
                                
                                et al.
                            
                            (2021). 
                            COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment. 
                            Journal of Community Health
                            , 46
                            (2)
                            , 270-277.
                            https://doi.org/10.1007/s10900-020-00958-x
                        

Identifiers

DOI: 10.1007/s10900-020-00958-x